United States · 
Who invested in Orasis Pharmaceuticals?
Orasis Pharmaceuticals's investors include Sequoia Capital, Catalio Capital Management and Maverick Ventures.
United States · Series D startup
Who invested in Orasis Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$68Mraised across 1 round since 2024, from 1 source
- Latest round
- Series D, $68MOct 2024
- Investors
- 3
The rounds
- Oct 2024
Founders and team
From Orasis Pharmaceuticals's own website: 3 on the team.
- Elad KedarChief Executive Officer
- Paul SmithPresident and Chief Operating Officer
- Iris MeisnerHead of Regulatory Affairs
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Orasis Pharmaceuticals
How much has Orasis Pharmaceuticals raised?
Orasis Pharmaceuticals has raised $68M across 1 round since 2024.
When did Orasis Pharmaceuticals last raise?
Orasis Pharmaceuticals's most recent round was a Series D of $68M in Oct 2024.
What was Orasis Pharmaceuticals's biggest round?
Its most recent round, $68M in Oct 2024, is also its largest on record.
Who backed Orasis Pharmaceuticals first?
Orasis Pharmaceuticals's first round on record, in Oct 2024, was backed by Sequoia Capital, Catalio Capital Management and Maverick Ventures.
What stage is Orasis Pharmaceuticals at?
Orasis Pharmaceuticals's latest named round is a Series D, in Oct 2024.
Where is Orasis Pharmaceuticals based?
Orasis Pharmaceuticals is based in the United States.
Companies like Orasis Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.